Hints and tips:
Related Special Reports
...Thomson said in future pandemics, vaccine makers were still likely to want to invest in creating a jab for a novel pathogen if they thought they had a chance of tackling it successfully....
...Given that close to three-quarters of the 224mn vaccine doses administered in Germany were produced by BioNTech in collaboration with Pfizer, the vast majority of the claims are being brought against the...
...But the chance for premium buyouts has not disappeared....
...It is under pressure because its US patent for Xtandi, a popular prostate cancer drug whose sales are shared with Pfizer, is expiring in 2027....
...A version of this article was first published by Nikkei Asia on February 14 2023. ©2023 Nikkei Inc. All rights reserved....
...Pfizer didn’t fall as much because of its wider array of products....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Indeed, there is an outside chance that they may exceed the target, given how low it is to begin with.”...
...My two mixed-breed dogs, Pfizer and AstraZeneca, adopted during the pandemic, climb on my knees, asking to be stroked....
...Speed was crucial, so Pfizer had to change how it worked....
...Moderna chief executive Stéphane Bancel argues that we now have a chance to build a fairer system....
...Its treatment was sold to the US government at $2,100 a dose, more than 100 times the price of vaccines from BioNTech/Pfizer and Moderna....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Yet the global need for coronavirus vaccines is so great that the pandemic’s next phase provides a chance for other players to break in....
...The EMA is conducting a rolling review of Sputnik V but has yet to authorise it for use across the bloc....
...Japan has also approved the BioNTech/Pfizer vaccine and expects to start inoculations of healthcare workers this week, giving renewed hope for a strong recovery this year and boosting the chances of holding...
...Kuala Lumpur also has agreements with Russia, for the Sputnik V vaccine, and with AstraZeneca....
...It is also a validation for investors who have poured money into vaccine businesses whose own products may now have a better chance of success....
...But while Marburg was grateful for the chance to rehabilitate its image, the town is deliberately doing little to draw attention to its new status, after the German government was reported to have expressed...
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...The Pfizer/BioNTech vaccine, the first to be deployed in the US and UK, officially requires two doses given 21 days apart....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Public health experts also welcomed the interim results of the phase 3 trials, saying it increased the chances that other potential vaccines relying on the novel mRNA technology would be effective....
...“I can say clearly and confidently that there are no plans to supply the private sector for the foreseeable future — no chance at all,” said Ben Osborn, Pfizer UK country manager, after the Medicines and...
...Russia’s Sputnik V jab carries deliberate cold war echoes....
International Edition